Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Highly accelerated region 1B (HAR1B, also known as HAR1R) is a long non-coding RNA (lncRNA) located at 20q13.33 in the human genome. HAR1B is part of the human accelerated region 1 (HAR1) locus, which is notable for its rapid evolution in humans compared to other vertebrates, suggesting a role in human-specific traits, possibly neurodevelopment. HAR1B is expressed in the adult brain and, like its counterpart HAR1A, may have functions in neurogenesis, though details remain unclear. Recent studies have linked HAR1B expression to pazopanib sensitivity in sarcoma cell lines and tissues, where higher HAR1B levels are associated with better response to the drug, and knockdown of HAR1B leads to pazopanib resistance. The molecular function of HAR1B is not well understood, and it is not known to encode a protein. HAR1B is a relatively understudied lncRNA, but emerging evidence suggests it may have clinical relevance in oncology, particularly as a potential biomarker for drug response.
Expression level of HAR1B correlates with pazopanib sensitivity in sarcoma cell lines; knockdown of HAR1B confers resistance to pazopanib, suggesting HAR1B may modulate cellular response to this drug, but exact molecular mechanism is unknown
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Highly accelerated region 1B (non-protein coding RNA) (HAR1B).